tirzepatide and pots Dr. Blitshteyn her research ream reported a patient with who improved on semaglutide (Ozempic). 🧠 While many patients with POTS, dysautonomia and Long COVID feel better on GLP-1 RAs Long-Term Tirzepatide Demonstrates Benefits in

For those considering Semaglutide GLP-1, it is important to work with a healthcare provider to determine if this treatment is suitable for individual health needs

The research linked the peptide to a 3-fold increase in uncoupling protein 1 (UCP1) content in interscapular brown adipose tissue (iBAT), indicating potentially better-supported thermogenic capacity

however, a potential side effect of the procedure is worsened infertility due to scarring or ovarian failure

Michael Koehler, Affinity's Medical Director While many clinics onboard patients in weeks or months, weve worked to streamline the process to a matter of days